Patents by Inventor Thomas J. Flotte

Thomas J. Flotte has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20040158192
    Abstract: A method for delivering compounds through epithelial cell layers using impulse transients is described. The method involves applying a compound to, e.g., the stratum corneum, of a patient and then inducing impulse transients to create transient increases in the permeability of epithelial tissue, thereby facilitating delivery of the compound across the epithelial cell layer.
    Type: Application
    Filed: February 5, 2004
    Publication date: August 12, 2004
    Applicant: The General Hospital Corporation, a Massachusetts corporation
    Inventors: Nikiforos Kollias, Apostolos G. Doukas, Thomas J. Flotte, Daniel J. McAuliffe, Shun Lee
  • Patent number: 6689094
    Abstract: A method for delivering compounds through epithelial cell layers using impulse transients is described. The method involves applying a compound to, e.g., the stratum corneum, of a patient and then inducing impulse transients to create transient increases in the permeability of epithelial tissue, thereby facilitating delivery of the compound across the epithelial cell layer.
    Type: Grant
    Filed: June 25, 2001
    Date of Patent: February 10, 2004
    Assignee: The General Hospital Corporation
    Inventors: Nikiforos Kollias, Apostolos G. Doukas, Thomas J. Flotte, Daniel J. McAuliffe, Shun Lee
  • Publication number: 20030176836
    Abstract: A device for transdermal delivery of a composition includes a housing partitioned into a delivery chamber arranged to contain the composition and a detonation chamber mechanically coupled to the delivery chamber. The detonation chamber is intended to contain an energetic material producing an impulse transient in response to a detonating stimulus. The housing is coupled to an energy coupling element, or detonator, for communicating energy provided by an external energy source into the detonating stimulus in the detonation chamber. The detonator can detonate the energetic material by causing an electrical discharge or spark within the detonation chamber. The detonator can be a piezoelectric film in electrical communication with the energetic material.
    Type: Application
    Filed: April 16, 2003
    Publication date: September 18, 2003
    Applicant: Massachusetts General Hospital,
    Inventors: Apostolos Doukas, Shun Kwan Lee, Thomas J. Flotte
  • Patent number: 6562004
    Abstract: A device for transdermal delivery of a composition includes a housing partitioned into a delivery chamber arranged to contain the composition and a detonation chamber mechanically coupled to the delivery chamber. The detonation chamber is intended to contain an energetic material producing an impulse transient in response to a detonating stimulus. The housing is coupled to an energy coupling element, or detonator, for communicating energy provided by an external energy source into the detonating stimulus in the detonation chamber. The detonator can detonate the energetic material by causing an electrical discharge or spark within the detonation chamber. The detonator can be a piezoelectric film in electrical communication with the energetic material.
    Type: Grant
    Filed: June 5, 2000
    Date of Patent: May 13, 2003
    Assignee: The Massachusetts General Hospital
    Inventors: Apostolos Doukas, Shun Kwan Lee, Thomas J. Flotte
  • Publication number: 20020062101
    Abstract: A method for delivering compounds through epithelial cell layers using impulse transients is described. The method involves applying a compound to, e.g., the stratum corneum, of a patient and then inducing impulse transients to create transient increases in the permeability of epithelial tissue, thereby facilitating delivery of the compound across the epithelial cell layer.
    Type: Application
    Filed: June 25, 2001
    Publication date: May 23, 2002
    Applicant: The General Hospital Corporation, Massachusetts corporation
    Inventors: Nikiforos Kollias, Apostolos G. Doukas, Thomas J. Flotte, Daniel J. McAuliffe, Shun Lee
  • Patent number: 6317624
    Abstract: The invention features an apparatus and method for demarcating the margins of a tumor in a target tissue by exposing the target tissue to radiation of a wavelength that induces fluorescence in tumorous but not in non-tumorous tissue. A decrease in fluorescence indicates the presence of tumor cells.
    Type: Grant
    Filed: May 5, 1998
    Date of Patent: November 13, 2001
    Assignee: The General Hospital Corporation
    Inventors: Nikiforos Kollias, Jerome D. Fallon, Thomas J. Flotte, Jessica L. Fewkes
  • Patent number: 6251099
    Abstract: A method for delivering compounds through epithelial cell layers using impulse transients is described. The method involves applying a compound to, e.g., the stratum corneum, of a patient and then inducing impulse transients to create transient increases in the permeability of epithelial tissue, thereby facilitating delivery of the compound across the epithelial cell layer.
    Type: Grant
    Filed: November 26, 1997
    Date of Patent: June 26, 2001
    Assignee: The General Hospital Corporation
    Inventors: Nikiforos Kollias, Apostolos G. Doukas, Thomas J. Flotte, Daniel J. McAuliffe, Shun Lee
  • Patent number: 5658892
    Abstract: A method of increasing delivery of a compound from an exterior region to an interior region of a cell without causing substantial lethality to the cell. The method includes the steps of first providing the compound in the exterior region proximal to a membrane of the cell, and then exposing the membrane to a time-dependent impulse transient characterized by a rise time and a magnitude. In this manner, the exposing step temporarily increases the permeability of the membrane, resulting in an increase in the diffusion of the compound from the exterior region to the interior region thereby enhancing the delivery of the compound without causing substantial lethality to the cell.
    Type: Grant
    Filed: February 7, 1995
    Date of Patent: August 19, 1997
    Assignee: The General Hospital Corporation
    Inventors: Thomas J. Flotte, Apostolos G. Doukas, Daniel J. McAuliffe, Therese M. Anderson
  • Patent number: 5614502
    Abstract: A method of treating diseases of cell proliferation in a patient such as neoplasms and rheumatoid arthritis including administering sub-toxic doses of a compound in combination with high pressure impulse transients. Methods are also provided for identifying compounds and impulse transient dosages useful for high pressure impulse transient chemotherapy.
    Type: Grant
    Filed: May 2, 1994
    Date of Patent: March 25, 1997
    Assignee: The General Hospital Corporation
    Inventors: Thomas J. Flotte, Apostolos Doukas, Daniel J. McAuliffe, Therese M. Anderson